DekaBank Deutsche Girozentrale
SLDB icon

DekaBank Deutsche Girozentrale’s Solid Biosciences SLDB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-833
Closed -$23K – 1357
2020
Q3 		$23K Buy
+833
New +$31.9K ﹤0.01% 1180

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SLDB Position: Q4 2020 in Review

DekaBank Deutsche Girozentrale sold out of Solid Biosciences (SLDB) in Q4 2020, closing a stake of 833 shares — an estimated $23K sold.

DekaBank Deutsche Girozentrale first reported a position in SLDB in Q3 2020 and held it in 1 quarter. The position peaked at $23K in Q3 2020. 75 funds tracked by Wall St. Rank hold SLDB as of Q4 2020.

  • DekaBank Deutsche Girozentrale reported no remaining Solid Biosciences position as of Q4 2020 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 833 Solid Biosciences shares in Q4 2020, an estimated $23K.
  • DekaBank Deutsche Girozentrale first reported a position in Solid Biosciences in Q3 2020 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's Solid Biosciences position peaked at $23K in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2020.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2020, filed 12 Mar 2021.